نتایج جستجو برای: alport syndrome

تعداد نتایج: 622022  

Journal: :The American Journal of Pathology 1999

Journal: :Kidney International Reports 2023

Glomerular diseases are the leading cause of ESKD worldwide. IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), Alport syndrome (AS), and diabetic kidney disease (DKD) important glomerular characterized by proteinuria, a predictor progression ESKD. Endothelin A (ETA) receptor activation drives inflammation, fibrosis. Therefore, atrasentan, potent selective ETA antagonist, has po...

Journal: :The Journal of clinical investigation 2010
Mari Tanaka Misako Asada Atsuko Y Higashi Jin Nakamura Akiko Oguchi Mayumi Tomita Sachiko Yamada Nariaki Asada Masayuki Takase Tomohiko Okuda Hiroshi Kawachi Aris N Economides Elizabeth Robertson Satoru Takahashi Takeshi Sakurai Roel Goldschmeding Eri Muso Atsushi Fukatsu Toru Kita Motoko Yanagita

The glomerular basement membrane (GBM) is a key component of the filtering unit in the kidney. Mutations involving any of the collagen IV genes (COL4A3, COL4A4, and COL4A5) affect GBM assembly and cause Alport syndrome, a progressive hereditary kidney disease with no definitive therapy. Previously, we have demonstrated that the bone morphogenetic protein (BMP) antagonist uterine sensitization-a...

Journal: :Journal of the American Society of Nephrology : JASN 2009
Valerie LeBleu Hikaru Sugimoto Thomas M Mundel Behzad Gerami-Naini Elizabeth Finan Caroline A Miller Vincent H Gattone Lingge Lu Charles F Shield Judah Folkman Raghu Kalluri

Patients with Alport syndrome progressively lose renal function as a result of defective type IV collagen in their glomerular basement membrane. In mice lacking the alpha3 chain of type IV collagen (Col4A3 knockout mice), a model for Alport syndrome, transplantation of wild-type bone marrow repairs the renal disease. It is unknown whether cell-based therapies that do not require transplantation...

Journal: :BMC Nephrology 2002
Liora Adler Roy Mathew Stephen Futterweit Rachel Frank Bernard G Gauthier Clifford E Kashtan Howard Trachtman

BACKGROUND Angiotensin converting enzyme inhibitors are routinely prescribed to patients with chronic kidney disease because of their known renoprotective effects. We evaluated the effect of short-term therapy with the angiotensin converting enzyme inhibitor, enalapril, in early Alport syndrome, defined as disease duration less than 10 years and a normal glomerular filtration rate. METHODS 11...

Journal: :Journal of the American Society of Nephrology : JASN 2009
Laurence Heidet Marie-Claire Gubler

Alport syndrome is a hereditary, progressive, hematuric nephropathy characterized by glomerular basement membrane abnormalities with frequent hearing defects and ocular anomalies. The disease is associated with mutations in genes encoding the alpha3, alpha4, or alpha5 chains of type IV collagen, COL4A3, or COL4A4 in the autosomal forms of the disease, COL4A5 in the more frequent X-linked variet...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید